OXT and major depressive disorder: Given previous reports on functional change of the neuroendocrine stress system (e.g., greater cortisol and oxytocin reactivity) during treatment response in adults with depressive symptoms (Atzil‐Slonim et al., 2022; Roque et al., 2020), treatment effects on neuroendocrine stress response alterations in youth with MDD should also be investigated in future work.